Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...

Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE: BMY) to develop FoundationOne®CDx as a ...

NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and insurance groups. Next-Generation Sequencing Trends Across Tum ...

Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...

Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The next-generation sequencing ...

Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...

Integrating metagenomics and bioinformatics enhances food safety, enabling early detection of microbial risks and supporting ...